The 14 references without contexts in paper A. Ostanin A., E. Gelfgadt L., M. Shipunov V., E. Shevela Ya., E. Kurganova V., L. Khvan A., A. Paltzev I., N. Starostina M., E. Chernykh R., А. Останин А., Е. Гельфгат Л., М. Шипунов В., Е. Шевела Я., Е. Курганова В., Л. Хван А., А. Пальцев И., Н. Старостина М., Е. Черных Р. (2014) “ПРОГНОСТИЧЕСКАЯ МОДЕЛЬ НЕИНВАЗИВНОЙ ДИАГНОСТИКИ ФИБРОЗА ПЕЧЕНИ У БОЛЬНЫХ ХРОНИЧЕСКИМИ ВИРУСНЫМИ ГЕПАТИТАМИ // A PREDICTIVE MODEL FOR NON-INVASIVE EVALUATION OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS VIRUS INFECTION” / spz:neicon:mimmun:y:2008:i:5:p:405-414

1
Adams L.A., Bulsara M., Rossi E., DeBoer B., Speers D., George J., Kench J., Farrell G., McCaughan G.W., Jeffrey G.P. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection // Clin. Chem. – 2005. – Vol. 51, N 10. – P. 1867-1873.
(check this in PDF content)
4
Bonacini M., Hadi G., Govindarajan S., Lindsay K.L. Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection // Am. J. Gastroenterol. – 1997. – Vol. 92. – P. 1302-1304.
(check this in PDF content)
6
Forns X., Ampurdans S., Llovet J.M., Aponte J., Quintó L., Martnez-Bauer E., Bruguera M., Snchez-Tapias J.M., Rods J. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model // Hepatology. – 2002. – Vol. 36. – P. 986-992.
(check this in PDF content)
7
Giannini E., Risso D., Botta F., Chiarbonello B., Fasoli A., Malfatti F., Romagnoli P., Testa E., Ceppa P., Testa R. Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease // Arch. Intern. Med. – 2003. – Vol. 163. – P. 218-224.
(check this in PDF content)
8
Imbert-Bismut F., Ratziu V., Pieroni L., Charlotte F., Benhamou Y., Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study // Lancet. – 2001. – Vol. 357. – P. 1069-1075.
(check this in PDF content)
9
Kelleher T.B., Mehta S.H., Bhaskar R., Sulkowski M., Astemborski J., Thomas D.L., Moore R.E., Afdhal N.H. Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index // J. Hepatology. – 2005. – Vol. 43. – P. 78-84.
(check this in PDF content)
10
Lu S.N., Wang J.H., Liu S.L., Hung C.H., Chen C.H., Tung H.D., Chen T.M., Huang W.S., Lee C.M., Chen C.C., Changchien C.S. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma // Cancer. – 2006. – Vol. 107, N 9. – P. 2212-2222.
(check this in PDF content)
11
Ohta T., Sakaguchi K., Fujiwara A., Fujioka S., Iwasaki Y., Makino Y., Araki Y., Shiratori Y. Simple surrogate index of the fibrosis stage in chronic hepatitis C patients using platelet count and serum albumin level // Acta Med. Okayama. – 2006. – Vol. 60, N 2. – P. 77-84.
(check this in PDF content)
12
Ono E., Shiratori Y., Okudaira T., Imamura M., Teratani T., Kanai F., Kato N., Yoshida H., Shiina S., Omata M. Platelet count reflects stage of chronic hepatitis C // Hepatol Res. – 1999. – Vol. 15. – P. 192-200.
(check this in PDF content)
13
Patel J., Gordon S.C., Oh E., Smith K., McHutchison J.G. A non-invasive panel of serum fibrosis markers can reliably differentiate hepatitis C patients with minimal fibrosis from those with fibrosis stages F2-F4 // 53rd Annual Meeting of the American Association for the Study of Liver Diseases. – Boston, 2002, [abstract 770].
(check this in PDF content)
14
Pohl A., Behling C., Oliver D., Kilani M., Monson P., Hassanein T. Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection // Am. J. Gastroenterol. – 2001. – Vol. 96. – P. 3142-3146.
(check this in PDF content)
15
Poynard T., Bedossa P., METAVIR and CLINIVIR cooperative studygroups. Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus // J. Viral. Hepatol. – 1997. – Vol. 4. – P. 199-208.
(check this in PDF content)
16
Sheth S.G., Flamm S.L., Gordon F.D., Chopra S. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection // Am. J. Gastroenterol. – 1998. – Vol. 93. – P. 44-48.
(check this in PDF content)
18
Wai C.T., Greenson J.K., Fontana R.J., Kalb fleisch J.D., Marrero J.A., Conjeevaram H.S., Lok A.S. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C // Hepatology. – 2003. –
(check this in PDF content)